心脏神经内分泌肿瘤的混合成像:联合即力量
心脏神经内分泌肿瘤(NETs)罕见且预后差,早期诊断困难,部分因心脏高代谢及邻近高代谢器官、解剖位置和体积小所致。混合成像(PET/CT、PET/MRI、SPECT/CT)同时提供解剖与功能信息,已用于心脏NETs诊断,但需前瞻性研究确认其临床与预后价值。
要点
- 心脏NETs罕见,早期诊断困难,预后差。
- 混合成像可同时提供解剖与功能信息,用于诊断心脏NETs。
- PET/CT、PET/MRI、SPECT/CT临床常用,具高敏感性和特异性。
核心结论
- 混合成像方法已确立在心脏神经内分泌肿瘤诊断中的地位,因其同时提供解剖和功能信息。
研究设计与样本
- 原文为综述/述评,未报告系统检索范围或样本量。
主要发现
- 心脏NETs罕见,临床结局很差,部分因转移但主要因激素活性表现。
- 心脏高代谢率且邻近其他高代谢器官,加上解剖位置和体积小,使诊断极具挑战。
- PET/CT、PET/MRI和SPECT/CT因提供重要代谢信息及高敏感性和特异性而广泛用于临床。
临床怎么用
- 对疑似心脏NETs患者,可考虑使用混合成像(PET/CT、PET/MRI、SPECT/CT)辅助诊断。
局限性
- 需前瞻性研究确认各种混合成像诊断技术在心脏NETs中的真实临床和预后价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiac neuroendocrine tumors (NETs) are particularly rare tumors that can lead to a very poor clinical outcome, partly because of metastases but mainly because of manifestations of the hormonal activity they exhibit. Prompt diagnosis is important in order to start the most effective treatment for their removal or management, with the fewest complications. They are often difficult to diagnose, especially in their early stages. One of the reasons for this is that the heart is an organ with a high rate of metabolism and is located in close proximity to other high-metabolism organs. In addition, the anatomic location and their small size render their diagnosis extremely challenging. In recent years, hybrid imaging methods have revolutionized the diagnostic approach to oncology patients and have established a place in the diagnosis of cardiac NETs, because they provide both anatomical and functional information at the same time. Positron emission tomography/computed tomography (PET/CT), PET/magnetic resonance imaging (PET/MRI) and single-photon emission computed tomography/CT (SPECT/CT) are widely used in clinical practice because of the very important metabolic information, the high sensitivity and specificity. However, prospective studies are needed to confirm the true clinical and prognostic value of various hybrid imaging diagnostic techniques in cardiac NETs.
引用
- Marketou ME, Kapsoritakis N, Bourogianni O, et al. Hybrid imaging of neuroendocrine tumors in the heart: Union is strength. J Nucl Cardiol. 2021. PMID: 34622428. doi:10.1007/s12350-021-02804-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。